New Rule Enables Use of EHRs for Prior Authorizations, Boosting Drug Cost Transparency
healthit.gov
|
Contributed by: Kate Gamble
Summary
The ASTP/ONC has finalized the HTI-4 rule to improve prescription drug cost transparency and streamline healthcare processes by leveraging certified Electronic Health Records (EHRs). This rule introduces a certification criterion for real-time prescription benefit checks, enabling patients and healthcare providers to compare drug prices and find cost-effective alternatives promptly. By facilitating real-time prior authorizations, the rule aims to enhance the efficiency of healthcare delivery, aligning with broader goals of the Department of Health and Human Services. The implications for healthcare professionals include reduced administrative burdens and improved access to necessary medications during patient encounters.
